Literature DB >> 12142561

Genetic aspects of stroke: human and experimental studies.

Fiona J Carr1, Martin W McBride, Hilary V O Carswell, Delyth Graham, Pamela Strahorn, James S Clark, Fadi J Charchar, Anna F Dominiczak.   

Abstract

As one of the leading causes of death within both the developed and developing world, stroke is a worldwide problem. Risk factors can be identified and controlled at the level of lifestyle changes; however, genetic components of stroke have yet to be identified. The identification of such genetic components is critical in the understanding, diagnosis, and treatment of stroke in the future. This review focuses on the genetic determinants of stroke in both human and experimental systems. Mendelian disorders, candidate genes, and twin studies provide evidence for a strong genetic component of stroke. Genome-wide scanning in both human and animal models has led to the identification of regions of the genome that contain genes for stroke susceptibility and sensitivity. Animal models of stroke allow for environmental control and genetic homogeneity, not possible within a human population, and therefore are essential for the dissection of this complex, multifactorial disorder. Future genetic and genomic strategies and their role in ultimate causative gene identification are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142561     DOI: 10.1097/00004647-200207000-00001

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  14 in total

Review 1.  Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapy.

Authors:  Andrea Lippoldt; Andreas Reichel; Ursula Moenning
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Sex differences in stroke.

Authors:  Roy A M Haast; Deborah R Gustafson; Amanda J Kiliaan
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

3.  Substrain differences, gender, and age of spontaneously hypertensive rats critically determine infarct size produced by distal middle cerebral artery occlusion.

Authors:  Hitonori Takaba; Kenji Fukuda; Hiroshi Yao
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

Review 4.  Association between Tumor Necrosis Factor-α (-238G/A and -308G/A) Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-Analysis.

Authors:  Pradeep Kumar; Shubham Misra; Amit Kumar; Awadh Kishor Pandit; Kamalesh Chakravarty; Kameshwar Prasad
Journal:  Pulse (Basel)       Date:  2016-02-17

5.  Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients.

Authors:  Chyi-Huey Bai; Jiunn-Rong Chen; Hou-Chang Chiu; Chia-Chi Chou; Lee-Young Chau; Wen-Harn Pan
Journal:  J Biomed Sci       Date:  2010-02-23       Impact factor: 8.410

6.  Animal models of ischemic stroke. Part one: modeling risk factors.

Authors:  Marco Bacigaluppi; Giancarlo Comi; Dirk M Hermann
Journal:  Open Neurol J       Date:  2010-06-15

Review 7.  Triggers and mediators of hemorrhagic transformation in cerebral ischemia.

Authors:  Xiaoying Wang; Eng H Lo
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

8.  Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study.

Authors:  Cara L Carty; Patrick Heagerty; Susan R Heckbert; Daniel A Enquobahrie; Gail P Jarvik; Scott Davis; Russell P Tracy; Alexander P Reiner
Journal:  J Atheroscler Thromb       Date:  2009-09-03       Impact factor: 4.928

Review 9.  Standards and pitfalls of focal ischemia models in spontaneously hypertensive rats: with a systematic review of recent articles.

Authors:  Hiroshi Yao; Toru Nabika
Journal:  J Transl Med       Date:  2012-07-06       Impact factor: 5.531

10.  Intracranial atherosclerotic disease.

Authors:  Maria Khan; Imama Naqvi; Asha Bansari; Ayeesha Kamran Kamal
Journal:  Stroke Res Treat       Date:  2011-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.